Skip to main content
logo
Lam Research Corporation (LRCX)
NASDAQ: LRCX · Real-Time Price · USD
305.77
-1.65 (-0.54%)
At close: Aug 6, 2026, 4:00 PM EDT
319.20
+13.43 (4.39%)
Pre-market: Aug 7, 2026, 8:47 AM EDT

Lam Research Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Quarter
Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Net Income
7,2656,7086,2135,8105,3584,6584,2944,0573,8283,6103,4583,9724,5114,9175,1254,8514,6054,5414,5904,265
Depreciation & Amortization
441.53420.33--386.28376.2-363.52359.7360.95362.69357.16342.43340.76333.33329.62333.74324.2319.43314.11
Stock-Based Compensation
386.38376.68--343.37328.18-305.86293.06282.46279.52282.7286.6287.69282.33272.08259.06245.8233222.28
Other Adjustments
-321.77-275.46---356.4-284.34--273.53-188.74-121.56-98.4-7.78-119.76-261.98-330.73-416.84-302.19-335.59-277.36-193.07
Change in Receivables
-----858.75---303.44---1,452----1,288---
Changes in Inventories
-----180.73---528.72----961.97----1,351---
Changes in Accounts Payable
----212---125.94----522.2---167.88---
Changes in Accrued Expenses
----328.25----304.65----108.83---123.46---
Changes in Unearned Revenue
----1,148----277.44---163.47---604.57---
Changes in Other Operating Activities
-1,914----206.73----15.54---136.02----53.12---
Operating Cash Flow
5,8586,9557,1226,3846,1734,4824,5585,2704,6524,9135,2544,9415,1794,5003,5313,8323,1004,0924,4993,403
Operating Cash Flow Growth (YoY)
-5.11%55.18%56.26%21.14%32.69%-8.77%-13.26%6.66%-10.17%9.16%48.78%28.94%67.08%9.98%-21.51%12.59%-13.61%37.99%92.13%47.65%

Investing Activities

Fiscal Quarter
Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Capital Expenditures
-966.41-949.8-906.25-833.72-759.19-687.74-503.34-430.27-396.67-374.59-390.4-438.5-501.57-548.64-574.56-549.67-546.03-524.91-469.14-422.72
Purchases of Investments
-------------0-299.36-542.52-567.82-714.47-1,206-1,664
Proceeds from Sale of Investments
-----011.2227.0637.7764.0581.9783.8898.1395.3488.6198.131,7342,6573,3023,604
Cash Acquisitions
-------------119.96-------
Other Investing Activities
44.2542.1340.2550.1351.097.298.79-6.71-11.71-13.64-14.57-13.7-11.1717.94-6.15-5.09-7.58-40.18-39.8-45.29
Investing Cash Flow
-922.15-907.66-866-783.59-708.09-680.45-479.9-406.48-370.61-324.18-316.15-481.44-534.56-555.32-565.55-112.22612.281,3771,5881,472

Financing Activities

Fiscal Quarter
Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Long-Term Debt Repaid
-755.43-755.56-508.4-507.97-507.49-506.95-3.98-3.93-256.1-257.22-258.37-274.46-23.21-23.18-22.79-7.41-11.89-831.9-846.33-849.23
Net Long-Term Debt Issued (Repaid)
-755.43-755.56-508.4-507.97-507.49-506.95-3.98-3.93-256.1-257.22-258.37-274.46-23.21-23.18-22.79-7.41-11.89-831.9-846.33-849.23
Issuance of Common Stock
173.41160.466.542.5142.57131.9910.7912.69135.52134.187.967.13121.01115.469.1611.74113.86108.2514.6719.33
Repurchase of Common Stock
-3,851-4,897-4,170-3,401-3,422-2,504-3,049-2,997-2,843-3,338-2,940-2,750-2,017-2,024-2,780-2,739-3,866-3,421-3,177-3,486
Net Common Stock Issued (Repurchased)
-3,678-4,737-4,163-3,399-3,280-2,372-3,038-2,984-2,707-3,204-2,932-2,743-1,896-1,909-2,771-2,727-3,752-3,313-3,163-3,467
Common Dividends Paid
-1,271-1,241-1,210-1,181-1,150-1,116-1,083-1,050-1,019-989.79-961.06-932.62-907.91-883.63-860.24-835.47-815.29-792.62-768.58-745.29
Other Financing Activities
-13.79-14.33-13.86-11.980.14-6.91-7.13-11.72-13.54-8.59-10.29-5.21-3.55-0.790.83-0.630.05-0.07-0.950.22
Financing Cash Flow
-5,718-6,747-5,749-4,959-4,937-4,001-4,004-3,929-3,996-4,460-4,043-3,846-2,831-2,816-3,546-3,462-4,579-4,937-4,676-4,963

Net Cash Flow

Fiscal Quarter
Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Foreign Exchange Rate Adjustments
-27.433.9111.27-1.4228.32-10.58-21.4111.34-22.37-11.28-5.136.020.13-18.03-20.82-43.38-30.23-12.84-13.51-0.64
Net Cash Flow
-809.71-696.15518.2639.79556.85-210.7851.88945.28263.43117.42889.46619.361,8141,111-601.35213.86-897.22518.931,397-88.93

Free Cash Flow

Fiscal Quarter
Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
4,8916,0056,2165,5505,4143,7944,0544,8394,2564,5384,8644,5024,6773,9522,9573,2822,5543,5674,0302,980
Free Cash Flow Growth (YoY)
-9.66%58.28%53.31%14.69%27.22%-16.40%-16.64%7.49%-9.02%14.84%64.49%37.17%83.17%10.79%-26.63%10.12%-21.16%33.57%93.30%43.42%
FCF Margin
21.05%27.70%30.23%28.33%29.37%22.14%25.01%31.04%28.55%31.87%33.97%28.43%26.84%20.96%15.52%18.24%14.82%21.31%24.39%18.92%
Free Cash Flow Per Share
3.884.744.884.334.202.923.113.693.223.473.703.413.452.892.142.361.822.512.822.07
Levered Free Cash Flow
4,0715,4234,7994,4695,7783,8403,7863,9863,5923,3393,1723,6173,0354,6864,8614,6243,8733,5083,5943,307
Unlevered Free Cash Flow
4,7726,1265,2464,9266,2344,3063,6953,8823,7633,5283,3973,9093,1164,8815,1044,8104,0524,4074,4884,246
SEC Filings: 10-K · 10-Q